The purpose of our paper is to propose a possible mechanism involving an immune-mediated disease process. A microbiological, biochemical and immunological approach to substantiate such a mechanism is presented.
Get full access to this article
View all access options for this article.
References
1.
VeltriRWSprinklePM: Serous otitis media immunoglobulin and lysozyme levels in middle ear fluids and serum. Ann Otol Rhinol Laryngol82:297–301, 1973.
2.
MogiGHonjoSMaedaS: Immunoglobulin E (IgE) in middle ear effusions. Ann Otol Rhinol Laryngol83:393–398, 1974.
3.
OgraPLBernsteinJMYurchakAM: Characteristics of secretory immune system in human middle ear: implications in otitis media. J Immunol112:488–495, 1974.
4.
JuhnSKHuffJSPaparellaMM: Lactate dehydrogenase activity and isoenzyme patterns in serous middle ear effusions. Ann Otol Rhinol Laryngol82:192–195, 1973.
5.
PlaiceCHJ: A note on the determination of serum Beta-glucuronidase activity. J Clin Pathol14:661–665, 1961.
6.
ChayenJBitenskyL: Lysosomal enzymes and inflammation with particular reference to rheumatoid diseases. Ann Rheum Dis30:522–536, 1971.
7.
PoskittTRFortwenglerHPLunskisBJ: Activation of the alternate pathway by autologous red cell stroma. J Exp Med138:715–722, 1973.
8.
GoldsteinIM: Lysosomal hydrolases and inflammatory materials, in WeissmanG (ed): Mediators of Inflammation.New York, Plenum Press, 1974, pp 51–84.
